These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 552898)

  • 1. Potentiation by clofibrate of in-vivo tumor inhibition by hydrazine sulfate and cytotoxic agents, in Walker 256 carcinosarcoma.
    Gold J
    Cancer Biochem Biophys; 1978; 3(1):41-5. PubMed ID: 552898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement by hydrazine sulfate of antitumor effectiveness of cytoxan, mitomycin C, methotrexate and bleomycin, in walker 256 carcinosarcoma in rats.
    Gold J
    Oncology; 1975; 31(1):44-53. PubMed ID: 51492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experimental data to substantiate the antitumor action of hydrazine sulfate].
    Tret'iakov AV; Filov VA; Riazanov EM; Tarkov AS
    Vopr Onkol; 1979; 25(6):100-3. PubMed ID: 462860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Selective action of hydrazine sulfate in combination with thiophosphamide on tumor cell mitochondria].
    Tret'iakov AV; Golovatova VA; Filov VA
    Vopr Onkol; 1982; 28(3):86-8. PubMed ID: 6461132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experimental and clinical data on the antitumor action of hydrazine sulfate].
    Seĭts IF; Gershanovich ML; Filov VA; Danova LA; Kondrat'ev VB
    Vopr Onkol; 1975; 21(1):45-52. PubMed ID: 1090085
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experimental data on the toxic action of hydrazine sulfate on the body and on a tumor].
    Filov VA; Stukov AN; Blank MA; Neĭshtadt EL
    Farmakol Toksikol; 1978; 41(2):203-5. PubMed ID: 658367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicity of intrathecally administered cytotoxic drugs and their antitumor activity against an intrathecal Walker 256 carcinosarcoma model for meningeal carcinomatosis in the rat.
    Kooistra KL; Rodriguez M; Powis G
    Cancer Res; 1989 Feb; 49(4):977-82. PubMed ID: 2912564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor effect of N alpha-benzyloxycarbonyl-N,N-bis-(2-halogenethyl)-hydrazide derivatives of amino acids.
    Karaivanova MH; Zakhariev SG; Golovinsky EV
    Neoplasma; 1980; 27(2):137-42. PubMed ID: 7393353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of antitumor activity of 2,4-diamino-5-(3',4'-dichlorophenyl)-6-methylpyrimidine and Baker's antifol (triazinate) with carboxypeptidase G1.
    Kalghatgi KK; Moroson BA; Horváth C; Bertino JR
    Cancer Res; 1979 Sep; 39(9):3441-5. PubMed ID: 476673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo synergy of vitamin K3 and methotrexate in tumor-bearing animals.
    Gold J
    Cancer Treat Rep; 1986 Dec; 70(12):1433-5. PubMed ID: 3791255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thiosemicarbazones and hydrazones of alpha-methylchalkone as potential chemotherapeutic agents.
    Prescott B
    Int J Clin Pharmacol Biopharm; 1975 Jun; 11(4):332-5. PubMed ID: 1099024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation of the cytotoxic action of melphalan and "activated" cyclophosphamide against cultured tumor cells by centrophenoxine.
    Sladek NE
    J Pharmacol Exp Ther; 1977 Jan; 200(1):17-24. PubMed ID: 319221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity of cis-dihalogenobis(1-phenyl-1,3-butanedionato) titanium(IV) compounds against Walker 256 carcinosarcoma. A new class of antineoplastic agents.
    Keller HJ; Keppler B; Schmähl D
    Arzneimittelforschung; 1982; 32(8):806-7. PubMed ID: 6890355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antineoplastic activity of new linear hydrazine derivatives.
    Fiszer-Maliszewska L; Peczyńska-Czoch W; Wieczorek J; Mordarski M; Balicki R; Nantka-Namirski P
    Arch Immunol Ther Exp (Warsz); 1987; 35(2):225-35. PubMed ID: 3447537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mechanism of increasing the effect of antineoplastic agents by hydrazine sulfate].
    Tret'iakov AV; Filov VA
    Vopr Onkol; 1977; 23(5):94-8. PubMed ID: 407720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation of antitumor effect of cyclophosphamide and hydrazine sulfate by treatment with the antidiabetic agent, 1-phenylethylbiguanide (phenformin).
    Dilman VM; Anisimov VN
    Cancer Lett; 1979 Oct; 7(6):357-61. PubMed ID: 509414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of ferromagnet particles on the growth of Walker carcinosarcoma 256 in Wistar rats].
    Volkonskiĭ VA
    Eksp Onkol; 1990; 12(2):74-6. PubMed ID: 2318139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on the solid Walker-carcinosarcoma 256 in the rat during administration of cytostatics].
    Mattern J; Volm M; Wayss K
    Arzneimittelforschung; 1972 Oct; 22(10):1721-2. PubMed ID: 4677063
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative study of cyclophosphamide, ifosfamide and trofosfamide on Walker-256 carcinosarcoma in embryonated chicken eggs].
    Norpoth K; Witting U; Rauen HM
    Arzneimittelforschung; 1974 Jan; 24(1):86-9. PubMed ID: 4406116
    [No Abstract]   [Full Text] [Related]  

  • 20. [Ineffectiveness of a drug combination on Yoshida sarcoma and Walker carcinosarcoma 256 of the rat and on Ehrlich carcinoma of the mouse].
    Zeller WJ; Wiessler M; Adzersen KH
    Arzneimittelforschung; 1972 Mar; 22(3):575-7. PubMed ID: 5067931
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.